Ramakanth Sarabu

1.9k total citations
37 papers, 1.3k citations indexed

About

Ramakanth Sarabu is a scholar working on Molecular Biology, Surgery and Organic Chemistry. According to data from OpenAlex, Ramakanth Sarabu has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Surgery and 10 papers in Organic Chemistry. Recurrent topics in Ramakanth Sarabu's work include Pancreatic function and diabetes (15 papers), Metabolism, Diabetes, and Cancer (14 papers) and Diabetes Management and Research (6 papers). Ramakanth Sarabu is often cited by papers focused on Pancreatic function and diabetes (15 papers), Metabolism, Diabetes, and Cancer (14 papers) and Diabetes Management and Research (6 papers). Ramakanth Sarabu collaborates with scholars based in United States, India and Switzerland. Ramakanth Sarabu's co-authors include Philip Garner, Joseph Grimsby, Franz M. Matschinsky, Robert F. Kester, Steven J. Berthel, Jefferson Tilley, Mark Dvorozniak, Wendy L. Corbett, Cheryl Spence and Kevin R. Guertin and has published in prestigious journals such as Science, Nature Biotechnology and Diabetes Care.

In The Last Decade

Ramakanth Sarabu

37 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ramakanth Sarabu United States 19 923 738 449 287 119 37 1.3k
Kevin R. Guertin United States 15 634 0.7× 398 0.5× 216 0.5× 204 0.7× 79 0.7× 24 1.0k
Paige E. Mahaney United States 15 487 0.5× 434 0.6× 203 0.5× 320 1.1× 66 0.6× 27 1.0k
Hisashi Shinkai Japan 14 573 0.6× 498 0.7× 436 1.0× 291 1.0× 95 0.8× 27 1.6k
Nancy-Ellen Haynes United States 6 410 0.4× 353 0.5× 277 0.6× 84 0.3× 79 0.7× 7 697
Fred T. Bizzarro United States 8 373 0.4× 335 0.5× 182 0.4× 160 0.6× 63 0.5× 9 615
Curtis A. Spilburg United States 22 673 0.7× 632 0.9× 170 0.4× 70 0.2× 62 0.5× 30 1.4k
Harry W. Chen United States 15 1.2k 1.3× 1.1k 1.5× 216 0.5× 52 0.2× 84 0.7× 19 1.8k
Ursula Müller‐Vieira Germany 24 454 0.5× 158 0.2× 422 0.9× 225 0.8× 25 0.2× 29 1.5k
Curt D. Haffner United States 16 616 0.7× 243 0.3× 120 0.3× 244 0.9× 119 1.0× 22 1.2k
Qiu Guo United States 16 662 0.7× 224 0.3× 135 0.3× 65 0.2× 54 0.5× 26 932

Countries citing papers authored by Ramakanth Sarabu

Since Specialization
Citations

This map shows the geographic impact of Ramakanth Sarabu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramakanth Sarabu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramakanth Sarabu more than expected).

Fields of papers citing papers by Ramakanth Sarabu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramakanth Sarabu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramakanth Sarabu. The network helps show where Ramakanth Sarabu may publish in the future.

Co-authorship network of co-authors of Ramakanth Sarabu

This figure shows the co-authorship network connecting the top 25 collaborators of Ramakanth Sarabu. A scholar is included among the top collaborators of Ramakanth Sarabu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramakanth Sarabu. Ramakanth Sarabu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Subbaiah, Murugaiah A. M., Nicholas A. Meanwell, John F. Kadow, et al.. (2018). Coupling of an Acyl Migration Prodrug Strategy with Bio-activation To Improve Oral Delivery of the HIV-1 Protease Inhibitor Atazanavir. Journal of Medicinal Chemistry. 61(9). 4176–4188. 13 indexed citations
2.
3.
4.
5.
Zelent, Bogumił, Carol Buettger, Joseph Grimsby, et al.. (2012). Thermal stabilty of glucokinase (GK) as influenced by the substrate glucose, an allosteric glucokinase activator drug (GKA) and the osmolytes glycerol and urea. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1824(5). 769–784. 14 indexed citations
6.
Doliba, Nicolai M., et al.. (2012). Repair of diverse diabetic defects of β‐cells in man and mouse by pharmacological glucokinase activation. Diabetes Obesity and Metabolism. 14(s3). 109–119. 20 indexed citations
7.
Matschinsky, Franz M., Bogumił Zelent, Nicolai M. Doliba, et al.. (2011). Research and Development of Glucokinase Activators for Diabetes Therapy: Theoretical and Practical Aspects. Handbook of experimental pharmacology. 357–401. 41 indexed citations
8.
Brinkman, J. A., Joseph Grimsby, Rachid Hamid, et al.. (2011). Discovery of benzothiazole-based adenosine A2B receptor antagonists with improved A2A selectivity. Bioorganic & Medicinal Chemistry Letters. 21(7). 1933–1936. 5 indexed citations
9.
Sidduri, Achyutharao, Joseph Grimsby, Wendy L. Corbett, et al.. (2010). 2,3-Disubstituted acrylamides as potent glucokinase activators. Bioorganic & Medicinal Chemistry Letters. 20(19). 5673–5676. 21 indexed citations
10.
Sarabu, Ramakanth, Steven J. Berthel, Robert F. Kester, & Jefferson Tilley. (2010). Novel glucokinase activators: a patent review (2008 – 2010). Expert Opinion on Therapeutic Patents. 21(1). 13–33. 41 indexed citations
11.
Brinkman, J. A., Alexander Flohr, Joseph Grimsby, et al.. (2010). 4-Substituted-7-N-alkyl-N-acetyl 2-aminobenzothiazole amides: Drug-like and non-xanthine based A2B adenosine receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(14). 4140–4146. 9 indexed citations
12.
Haynes, Nancy-Ellen, Wendy L. Corbett, Fred T. Bizzarro, et al.. (2010). Discovery, Structure−Activity Relationships, Pharmacokinetics, and Efficacy of Glucokinase Activator (2R)-3-Cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675). Journal of Medicinal Chemistry. 53(9). 3618–3625. 36 indexed citations
13.
Berthel, Steven J., et al.. (2008). Glucokinase Activators for the Potential Treatment of Type 2 Diabetes. Current Topics in Medicinal Chemistry. 8(17). 1524–1532. 44 indexed citations
14.
Sarabu, Ramakanth & Joseph Grimsby. (2005). Targeting glucokinase activation for the treatment of type 2 diabetes--a status review.. PubMed. 8(5). 631–7. 43 indexed citations
15.
Grimsby, Joseph, Ramakanth Sarabu, Wendy L. Corbett, et al.. (2003). Allosteric Activators of Glucokinase: Potential Role in Diabetes Therapy. Science. 301(5631). 370–373. 408 indexed citations
16.
Falcioni, Fiorenza, Kouichi Ito, Damir Vidović, et al.. (1999). Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules. Nature Biotechnology. 17(6). 562–567. 49 indexed citations
17.
Sarabu, Ramakanth, et al.. (1993). Design, synthesis, and three-dimensional structural characterization of a constrained Ω-loop excised from interleukin-1α. Tetrahedron. 49(17). 3629–3640. 8 indexed citations
18.
Garner, Philip, et al.. (1992). Synthesis of 2-aminopurine nucleosides via regiocontrolled glycosylation. Tetrahedron. 48(21). 4259–4270. 28 indexed citations
19.
Tilley, Jefferson, Waleed Danho, I. D. KULESHA, et al.. (1992). Structure activity of C‐terminal modified analogs of Ac‐CCK‐7. International journal of peptide & protein research. 39(4). 322–336. 14 indexed citations
20.
Garner, Philip & Ramakanth Sarabu. (1986). Stereodivergent synthesis of threo and erythro 6-amino-6-deoxyheptosulose derivatives via an optically active oxazolidine aldehyde. The Journal of Organic Chemistry. 51(13). 2609–2612. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin R. Guertin Breakdown of academic impact, for papers by Paige E. Mahaney Breakdown of academic impact, for papers by Hisashi Shinkai Breakdown of academic impact, for papers by Nancy-Ellen Haynes Breakdown of academic impact, for papers by Fred T. Bizzarro Breakdown of academic impact, for papers by Curtis A. Spilburg Breakdown of academic impact, for papers by Harry W. Chen Breakdown of academic impact, for papers by Ursula Müller‐Vieira Breakdown of academic impact, for papers by Curt D. Haffner Breakdown of academic impact, for papers by Qiu Guo
Rankless by CCL
2026